Pseudomonas aeruginosa infections in the neonatal intensive care unit

Seminars in Perinatology

Volumn 26, Issue 5, 2002, Pages 332-339

  Foca, Marc D ^a  

^a Och Spine at New York Presbyterian Hospitals   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMINOGLYCOSIDE ANTIBIOTIC AGENT; AMPICILLIN; CARBAPENEM; CEFOTAXIME; CEFTAZIDIME; CEPHALOSPORIN DERIVATIVE; CHLORAMPHENICOL; CIPROFLOXACIN; CLAVULANIC ACID; GENTAMICIN; MACROLIDE; MEROPENEM; PIPERACILLIN; QUINOLINE DERIVED ANTIINFECTIVE AGENT; QUINOLONE DERIVATIVE; TAZOBACTAM; TETRACYCLINE; TICARCILLIN; TOBRAMYCIN; TRIMETHOPRIM; VANCOMYCIN; VIRULENCE FACTOR;

ANTIBIOTIC RESISTANCE; BACTERIAL COLONIZATION; BACTERIAL VIRULENCE; CONJUNCTIVITIS; GRAM NEGATIVE INFECTION; GRAM NEGATIVE SEPSIS; HAND; HOSPITAL INFECTION; HOSPITAL PERSONNEL; HUMAN; NEWBORN CARE; NEWBORN INTENSIVE CARE; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; PSEUDOMONAS AERUGINOSA; REVIEW; SYNDROME;

EID: 0036803935     PISSN: 01460005     EISSN: None     Source Type: Journal    
DOI: 10.1053/sper.2002.36266     Document Type: Article

References (51)

1. Prince AS: Pseudomonas aeruginosa, in Long SS, Pickering LK, Prober CG (eds): Principles and Practice of Pediatric Infectious Diseases (Ed 2). New York, NY, Churchill Livingstone, 2002 (in press)
2. Baltch AL, Smith RP (eds): Pseudomonas Aeruginosa Infections and Treatment. New York, NY, Marcel Dekker, 1994
3. Zafar N, Wallace CM, Kieffer P, et al: Improving survival of vulnerable infants increases neonatal intensive care unit nosocomial infection rate. Arch Pediatr Adolesc Med 155:1098-1103, 2001
4. Rais-Bahrami K, Platt P, Naqvi M: Neonatal pseudomonas sepsis: Even early diagnosis is too late. Clin Pediatr 29:444, 1990
5. Asay LD, Koch R: Pseudomonas infections in infants and children. N Eng J Med 262:1062-1066, 1960
6. Sommer LS, Flavour CB: Biologic complications of penicillin therapy. Am J Med 7:511-517, 1949
7. Brown DG, Baublis J: Reservoirs of pseudomonas in an intensive care unit for newborn infants: Mechanisms of control. J Pediatr 90:453-457, 1977
8. Sever JL: Possible role of humidifying equipment in spread of infections from the newborn nursery. Pediatrics 24:50-53, 1959
9. Barrie D: Incubator-borne pseudomonas pyocyanea infection in a newborn nursery. Arch Dis Child 40:555-559, 1965
10. Becks VE, Lorenzoni NM: Pseudomonas aeruginosa outbreak in a neonatal intensive care unit: A possible link to contaminated hand lotion. Am J Infect Control 23:396-398, 1995
11. Chandrashekar MR, Rathish KC, Nagesha CN: Reservoirs of nosocomial pathogens in neonatal intensive care unit. J Indian Med Assoc 95:72-77, 1997
12. Gaynes RP, Edwards JR, Jarvis WR et al: Nosocomial infections among neonates in high-risk nurseries in the United States. Pediatrics 98:357-361, 1996
13. Cordero L, Sananes M, Ayers LW: Bloodstream infections in a neonatal intensive-care unit: 12 Years experience with an antibiotic control program. Infect Control Hosp Epidemiol 20:242-246, 1999
14. Sohn AH, Garrett DO, Sinkowitz-Cochran RL et al: Prevalence of nosocomial infections in neonatal intensive care unit patients: Results from the First National Point-Prevalence Survey. J Pediatr 139:821-827, 2001
15. Leigh L, Stoll BJ, Rahman M et al: Pseudomonas aeruginosa infection in very low birth weight infants: A case control study. Pediatr Infect Dis J 14:367-371, 1995
16. Moolenaar RL, Crutcher JM, San Joaquin VH, et al: A prolonged outbreak of Pseudomonas aeruginosa in a neonatal intensive care unit: Did staff fingernails play a role in disease transmission? Infect Control Hosp Epidemiol 21:80-85, 2000
17. Reybrouck G: Role of the hands in the spread of nosocomial infection I. J Hosp Infect 4:103-110, 1983
18. Salzman TC, Clark JJ, Klemm L: Hand contamination of personnel as a mechanism of cross infection in nosocomial infections with antibiotic-resistant Escherichia coli and Klebsiella-Aerobacter. Antimicrob Agents Chemo (Ed 7):97-100, 1967
19. Knittle MA, Eitzman DV, Baer H: Role of hand contamination of personnel in the epidemiology of gram-negative nosocomial infections. J Pediatr 86:433-437, 1975
20. Adams BG, Marrie TJ: Hand carriage of aerobic gram-negative rods by health care personnel. J Hyg 89:2346, 1982
21. Guenthner SH, Hendley JO, Wenzel RP: Gram-negative bacilli as nontransient flora on the hands of hospital personnel. J Clin Microb 25:488-490, 1987
22. Horn WA, Larson EL, McGinley KJ et al: Microbial flora on the hands of health care personnel: Differences in composition and antimicrobial resistance. Infect Control Hosp Epidemiol 9:189-193, 1988
23. Larson EL: Persistent carriage of gram-negative bacteria on hands. Am J Infect Control 9:112-119, 1981
24. Edel E, Houston S, Kennedy V, et al: Impact of a 5-minute scrub on the microbial flora found on artificial, polished, or natural fingernails of operating room personnel. Nurs Res 47:54-59, 1998
25. Widmer AF, Wenzel RP, Trilla A, et al: Outbreak of Pseudomonas aeruginosa infections in a surgical intensive care unit: Probable transmission via hands of a health care worker. Clin Infect Dis 16:372-376, 1993
26. Foca MD, Jakob K Whittier S, et al: Endemic Pseudomonas aeruginosa infection in a neonatal intensive care unit. N Eng J Med 343:695-700, 2000
27. Pollack M: Pseudomonas aeruginosa, in Mandell GL, Bennett JE, Dolin R (eds): Principles and Practice of Infectious Diseases (Ed 5). New York, NY, Churchill Livingstone, 2000, pp 2310-2335
28. Woods DE, Straus DC, Johanson WG, Jr, et al: Role of pili in adherence of Pseudomonas aeruginosa to mammalian buccal epithelial cells. Infect Immun 29:1146-1151, 1980
29. Ramphal R, Small PM, Shands JW, et al: Adherence of Pseudomonas aeruginosa to tracheal epithelial cells injured by influenza infection or by endotracheal intubation. Infect Immun 27:614-619, 1980
30. Boyd A, Chakrabarty AM: Pseudomonas aeruginosa Biofilms: Role of the alginate exopolysaccharide. J Ind Microbiol 15:162-168, 1995
31. Rumbaugh KP, Griswold JA, Hamood AN: The role of quorum sensing in the in vivo virulence of Pseudomonas aeruginosa. Microbiol Infect 2:1721-1731, 2000
32. Anwar H, Strap JL, Chen K, et al: Dynamic interactions of biofilms of mucoid pseudomonas aeruginosa with tobramycin and piperacillin. Antimicrob Agents Chemother 36:1208-1214, 1992
33. Tang HB, DiMango E, Bryan R, et al: Contribution of specific Pseudomonas aeruginosa virulence factors to pathogenesis of pneumonia in a neonatal model of infection. Infect Immun 64:37-43, 1996
34. Morihara K: Production of elastase and proteinase by Pseudomonas aeruginosa. J Bacteriol 88:745-757, 1964
35. Azghani AO, Connelly JC, Peterson BT, et al: Effects of Pseudomonas aeruginosa elastase on alveolar epithelial permeability in guinea pigs. Infect Immun 61:433-438, 1990
36. Bishop MB, Baltch AL, Hill LA, et al: The effect of pseudomonas aeruginosa cytotoxin and toxin a on human polymorphonuclear leukocytes. J Med Microbiol 24:315-324, 1987
37. Iglewski BH, Kabat D: NAD-dependent inhibition of protein synthesis by pseudomonas aeruginosa toxin. Proc Natl Acad Sci USA 22:2284-2288, 1975
38. Vidal DR, Garrone P, Banchereau J: Immunosuppressive efects of Pseudomonas aeruginosa exotoxin A on human B-Lymphocytes. Toxicon 31:27-34, 1993
39. Staugas REM, Harvey DP, Ferrante A, et al: Induction of tumor necrosis factor (TNF) and Interleukin 1 (IL1) by Pseudomonas aeruginosa and exotoxin A-induced suppression of lymphoproliferation and TNF, lymphotoxin, gamma interferon, and IL 1 production in human leukocytes. Infect Immun 60:3162-3168, 1992
40. Pederson KJ, Vallis AJ, Aktories K, et al: The aminoterminal domain of pseudomonas aeruginosa exos disrupts actin filaments via small-molecular-weight gtpbinding proteins. Molec Microbiol 32:393-401, 1999
41. Lee KA: Type III Secretion Systems: Machines to deliver bacterial proteins into eukaryotic cells? Trends Micro 5:148-156, 1997
42. Aldridge P, Hughes KT: How and when are substrates selected for type III secretion? Trends Micro 9:209-214, 2001
43. Prince AS: Pseudomonas aeruginosa, in Katz SL, Gershon AA, Hotez PJ (eds): Krugmans Infectious Diseases of Children (Ed 11). St Louis, MO, Mosby, 2002 (in press)
44. Ghosal SP, Gupta PC, Mukherjee AK: Noma neonatorum: Its aetiopathogenesis. Lancet 2:289-291, 1978
45. Freeman AF, Mancini AJ, Yogev R: Is noma neonatorum a presentation of ecthyma gangrenosum in the newborn? Ped Infect Dis J 21:83-85, 2002
46. Cordero L, Sananes M, Coley B, et al: Ventilator-associated pneumonia in vely low-birth-weight infants at the time of nosocomial bloodstream infection and during airway colonization with Pseudomonas aeruginosa. Am J Infect Control 28:333-339, 2000
47. Schaad UB: Use of quinolones in pediatrics. Eur J Clin Microbiol Infect Dis 10:355-360, 1991
48. Schaad UB, Stoupis C, Wedgwood J, et al: Clinical, radiologic and magnetic resonance monitoring for skeletal toxicity in pediatric patients with cystic fibrosis receiving a three-month course of Ciprofloxacin. Pediatr Infect Dis J 10:723-729, 1991
49. Elenberg E, Travis LB: Urinary tract infection and perinephric/intranephric abscess, in Burg FD, Ingelfinger JR, Polin RA, Geshon AA (eds): Current Pediatric Therapy (Ed 17). Philadelphia, PA, Saunders, 2002, pp 772-777
50. Miller MB, Bassler BL: Quorom sensing in bacteria. Annu Rev Microbiol 55:165-199, 2001
51. Nikaido H: Prevention of drug access to bacterial targets: Permeability barriers and active efflux. Science 264:382-387, 1994